Cancer of the Skin

Adjuvant Therapy for Cutaneous Melanoma

Key Points Chemotherapy regimens, non-specific immunostimulants and vaccines alone have failed to show any survival benefit in the adjuvant setting. High-dose interferon-α2b is the only approved drug shown to improve relapse-free and overall survival in large multi-institutional randomized controlled trials…

Reconstructive Surgery for Skin Cancer

Key Points Strategies employed in skin cancer reconstruction balance the requirements of the resulting wound defect – location, dimension, functional properties and aesthetics – to achieve the goal of a well-healed durable reconstruction with minimal donor morbidity. Options for reconstruction…

Surgical Excision of Melanoma

Key Points Surgical excision is the cornerstone for the initial management of primary melanoma. The major focus of surgical excision for melanoma is to remove the primary tumor and any local disease. The initial treatment for melanoma should include excision…

Mohs Surgery

Key Points Mohs micrographic surgery (MMS) involves the extirpation of tumor and correct processing of tissue with frozen section histology to ensure that 100% of the margin is examined and has the advantage of sparing normal tissue. MMS has the…

Surgical Excision for Non-Melanoma Skin Cancer

Key Points Non-melanoma skin cancer (NMSC) is the most common type of cancer and has multiple management options. Surgical excision remains an efficient, effective, and safe method for the treatment of these tumors, particularly with thorough perioperative planning. Excision has…

Photodynamic Therapy in Skin Cancer

Key Points Photodynamic therapy (PDT) is a selective non-invasive therapy for non-hyperkeratotic actinic keratoses, in-situ squamous cell carcinoma, and superficial and thin nodular basal cell carcinomas. PDT offers particular advantages for large and multiple lesions and those in sites where…

Immune Response Modulators in the Treatment of Skin Cancer

Key Points Interferons (IFNs) have antiproliferative, antiangiogenic and immunomodulatory properties that can be used to treat skin cancer, including malignant melanoma, Kaposi sarcoma (KS), basal cell carcinoma (BCC) and cutaneous T-cell lymphoma (CTCL). An immune response modifier stimulates both innate…